Medicare Enrolled
Dr. Dominic Dekeratry, M.D.
Critical Care Medicine · Georgetown, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dekeratry from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dekeratry?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dekeratry
Dr. Dominic Dekeratry is a critical care medicine specialist in Georgetown, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Dekeratry performed 3,105 Medicare services across 2,408 unique beneficiaries.
Between the years covered by Open Payments, Dr. Dekeratry received a total of $10,679 from 48 pharmaceutical and/or device companies across 344 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in critical care medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dekeratry is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 6% volume in TX
$10,679 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,105
Medicare services
Top 6% in TX for critical care medicine
2,408
Unique beneficiaries
$58
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~155 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
562 | $18 | $52 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
547 | $39 | $109 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
312 | $91 | $231 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
254 | $23 | $66 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
234 | $89 | $248 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
203 | $39 | $105 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
186 | $28 | $75 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
147 | $161 | $532 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
118 | $60 | $154 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
99 | $45 | $122 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
97 | $131 | $338 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
78 | $133 | $348 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
69 | $88 | $223 |
| Chronic care management, first 30 minutes This service covers the initial 30 minutes of care coordination for patients with two or more chronic conditions. It is provided personally by a healthcare professional each calendar month. |
43 | $63 | $165 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
32 | $65 | $176 |
| New patient office visit, complex (60-74 min) | 31 | $150 | $427 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
28 | $35 | $92 |
| Additional 30 minutes of critical care This code represents an additional 30 minutes of critical care services provided beyond the initial critical care time period. |
26 | $82 | $232 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
20 | $62 | $157 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
19 | $156 | $397 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$10,679
Total received (2018-2024)
Avg $1,526/year across 7 years
Top 13% in TX for critical care medicine
48
Companies
344
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,446 (60.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,117 (38.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$116 (1.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,494
2023
$473
2022
$540
2021
$742
2020
$745
2019
$5,448
2018
$1,237
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
CSA Medical, Inc
$4,117
GlaxoSmithKline, LLC.
$2,102
Noah Medical Corporation
$930
Boehringer Ingelheim Pharmaceuticals, Inc.
$485
AstraZeneca Pharmaceuticals LP
$444
Mylan Specialty L.P.
$292
Insmed, Inc.
$281
Sunovion Pharmaceuticals Inc.
$191
Astellas Pharma US Inc
$154
PFIZER INC.
$148
Philips Electronics North America Corporation
$143
Regeneron Healthcare Solutions, Inc.
$133
Genentech USA, Inc.
$131
Electromed, Inc.
$100
United Therapeutics Corporation
$89
Grifols USA, LLC
$62
Olympus America Inc.
$50
Olympus Corporation of the Americas
$49
Paratek Pharmaceuticals, Inc.
$47
ANI Pharmaceuticals, Inc.
$46
Pulmonx Corporation
$43
Allergan Inc.
$40
GENZYME CORPORATION
$39
Melinta Therapeutics, LLC
$38
E.R. Squibb & Sons, L.L.C.
$37
Novartis Pharmaceuticals Corporation
$37
Tactile Systems Technology Inc
$35
Vifor Pharma, Inc.
$34
Mallinckrodt Hospital Products Inc.
$34
Teva Pharmaceuticals USA, Inc.
$32
Shire North American Group Inc
$28
Circassia Pharmaceuticals Inc
$26
Mallinckrodt LLC
$25
Janssen Pharmaceuticals, Inc
$21
ADMA BioManufacturing LLC
$21
La Jolla Pharmaceutical Company
$21
Covis Pharma GmBH
$20
Takeda Pharmaceuticals U.S.A., Inc.
$17
Bolton Medical Inc
$17
Nabriva Therapeutics, plc
$16
Amgen Inc.
$16
Inogen, Inc.
$15
AbbVie Inc.
$14
Merck Sharp & Dohme Corporation
$13
Veran Medical Technologies, Inc.
$12
Allergan, Inc.
$12
Covidien LP
$12
Boston Scientific Corporation
$11
Top 3 companies account for 66.9% of total payments
Associated products mentioned in payments ›
(8874) inCourage · (8876) Vest Therapy Und · 120V · 60Hz · ACQUIRE · ACTHAR · AIRSUPRA · ALVESCO · ANORO · ANORO ELLIPTA · AVYCAZ · AirDuo Digihaler · Arikayce · BREO · BREO ELLIPTA · BREZTRI · BROVANA · CHARTIS CATHETER · CREON · CRESEMBA · Cresemba · DUPIXENT · ELIQUIS · Esbriet · FASENRA · Flexitouch Plus · GALAXY · GLASSIA · InogenOne · LIBTAYO · LONHALA MAGNAIR · NUCALA · NUZYRA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · PURIFIED CORTROPHIN GEL · Perforomist · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · Relay Plus · Respiratoriy Care Undiv · SMARTVEST · SPiN Thoracic Navigation System · STIOLTO RESPIMAT · SYMBICORT · Spin · SuperDimension · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · Utibron · Vabomere · Wellcentive Undiv · XARELTO · XERAVA · XOLAIR · Xenleta · Xolair · YUPELRI · Yupelri · ZERBAXA · Zemaira · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (60%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $344 per 100 Medicare services performed
Geographic Context
Critical care medicines within 10 mi
10
Per 100K population
1.6
County median income
$108,309
Nearest hospital
ROCK SPRINGS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Dekeratry is a clinical cardiology specialist, with above-average Medicare volume (top 6% in TX), with low-engagement industry engagement in the top 13% of TX peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Dekeratry experienced with expiratory airflow and volume test?
Based on Medicare claims data, Dr. Dekeratry performed 562 expiratory airflow and volume test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dekeratry receive payments from pharmaceutical companies?
Yes. Dr. Dekeratry received a total of $10,679 from 48 companies across 344 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dekeratry's costs compare to other critical care medicines in Georgetown?
Dr. Dekeratry's average Medicare payment per service is $58. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dekeratry) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Critical Care Medicines in Georgetown
Browse critical care medicines in Georgetown ranked by procedure volume and transparency data.
Highest volume
Top Critical Care Medicines in TX
Critical care medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Critical Care Medicines in TX
Which TX critical care medicines receive the most from drug and device companies.
By company
CSA Medical, Inc Payments to Doctors
See all physicians who received payments from CSA Medical, Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Noah Medical Corporation Payments to Doctors
See all physicians who received payments from Noah Medical Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology